ArticleFrontiers in gastroenterology (Lausanne, Switzerland)2026

NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trial.

Ruihong Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.